机构:[1]Liver Transplantation Center and HBP Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China.四川省肿瘤医院[2]School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.[3]State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau SAR, China.[4]Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China.四川省肿瘤医院
The Excellent Youth Fund of Sichuan
Cancer Hospital, Grant/Award Number:
YB2024002; Sichuan Provincial Science
and Technology Plan Project,
Grant/Award Number: 2023YFSY0043
第一作者机构:[1]Liver Transplantation Center and HBP Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China.[2]School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.
共同第一作者:
通讯作者:
通讯机构:[1]Liver Transplantation Center and HBP Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China.[4]Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China.[*1]Liver Transplantation Center and HBP Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China[*2]Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China
推荐引用方式(GB/T 7714):
Zhong Deyuan,Shi Ying,Ma Wenzhe,et al.Single-cell profiling reveals the metastasis-associated immune signature of hepatocellular carcinoma[J].IMMUNITY INFLAMMATION AND DISEASE.2024,12(5):e1264.doi:10.1002/iid3.1264.
APA:
Zhong Deyuan,Shi Ying,Ma Wenzhe,Liang Yuxin,Liu Hanjie...&Shang Jin.(2024).Single-cell profiling reveals the metastasis-associated immune signature of hepatocellular carcinoma.IMMUNITY INFLAMMATION AND DISEASE,12,(5)
MLA:
Zhong Deyuan,et al."Single-cell profiling reveals the metastasis-associated immune signature of hepatocellular carcinoma".IMMUNITY INFLAMMATION AND DISEASE 12..5(2024):e1264